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Tbjective: Infections are among the most common and serious complications of
entricular assist device implantation. These infections generally occur within
he first 2 months after surgery. The basis for this high incidence of infection is
ot well established, so a murine intravascular infection model was developed
ith aortic implantation of the textured polyurethane patch material currently
sed in HeartMate ventricular assist devices (Thoratec Corporation Pleasanton,
alif).
ethods: Polyurethane patch material was placed in the wall of the mouse descend-
ng aorta. Mice were then infected with Staphylococcus aureus 1 or 14 days after
mplantation. In vitro adhesion studies were conducted with polyurethane mem-
ranes coated with endothelial cells and membranes coated with fibrinogen.
esults: Mice were susceptible to infection in both dose- and time-dependent
ashions. The patch material was significantly more susceptible to infection at day
than day 14. Immunohistologic and morphologic studies demonstrated that the
D31 cells deposited on the membrane surface phenotypically appeared to be
ndothelial cells. In vitro adhesion studies of polyurethane membranes coated with
ndothelial cells showed them to be less susceptible to S aureus binding than were
embranes coated with fibrinogen.
onclusion: Textured polyurethane membranes are less susceptible to infection as
ellular deposition occurs. The time frame within which these membranes become
opulated with cellular material is consistent with the time-dependent clinical
ncidence of infection. Cellular coating of polyurethane may provide a strategy for
educing the risk of infection.
echanical circulatory support devices, specifically left ventricular assist
devices (LVADs), are a major form of therapy for patients with advanced
heart failure.1 Originally introduced as a bridge to cardiac transplantation,
hey have recently been approved as destination therapy for patients with end-stage
eart failure who are ineligible for cardiac transplantation. LVADs improve survival
nd quality of life for patients with advanced heart failure who are ineligible for
ransplantation2; however, a serious limitation to the long-term use of LVADs has
een the high incidence of device-related infections.3-6 These infections, ranging
rom driveline infections to device-associated endocarditis, occur in 20% to 50% of
atients and cause significant morbidity and mortality. A combination of factors is
elieved to be responsible for the high incidence of life-threatening infection,
ncluding the immunocompromised host, the presence of a transcutaneous driveline,
he numerous invasive procedures performed on these patients, and the presence of
large prosthetic device.
he Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 5 1147
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1
CSPStaphylococcus aureus is among the most common of
he pathogens that are associated with LVAD-related infec-
ions.3-6 We therefore elected to use S aureus to investigate
he pathogenesis of LVAD-related endovascular infections,
ocusing on the initial colonization step in which bacteria
dhere to the neointimal lining that forms on the surface of
he textured HeartMate (Thoratec Corporation Pleasanton,
alif) LVAD polyurethane membrane. These membranes
ave already been shown to reduce the incidence of throm-
oembolic complications associated with LVAD implanta-
ion.7 To mimic the clinical situation, we developed an in
ivo murine aortic polyurethane patch model.8 In this
odel, the blood-contacting surface of the membrane was
oated with cellular material in a time-dependent manner.
ith this model, we aimed to establish an animal model of
VAD-associated infection and to determine the effect of
ellular population on the susceptibility of the polyurethane
atch to S aureus infection.
aterials and Methods
olyurethane Patch Material
olyurethane patch material was provided by Thoratec Corpora-
ion, the makers of the HeartMate LVAD. Except for its thickness
0.125 mm), the patch material was identical to the material used
or the inner surface of the HeartMate LVAD. The patch size was
 4 mm.
nimals
ale C57BL/6J mice from 3 to 4 months old (Jackson Laborato-
ies, Bar Harbor, Mass) were maintained for at least a week on a
ight-dark (12 hour/12 hour) cycle at 25°C before the experiment.
ll procedures were performed according to protocols approved
y the Columbia University Institutional Animal Care and Use
ommittee.
atch Implantation Procedure
he polyurethane patch was implanted in the mouse abdominal
orta as described previously.8 Briefly, the mice were anesthetized
y intraperitoneal injection of ketamine and xylazine. An intra-
eritoneal injection of heparin (300 IU/kg) was given before the
rocedure. The abdomen was opened through a midline incision,
nd the abdominal aorta and the inferior vena cava were exposed
nd carefully freed. The segment of the abdominal aorta between
he renal arteries and the aortic bifurcation was temporally oc-
luded with microvascular clamps (Roboz Surgical Instrument Co,
nc, Gaithersburg, Md), and the aorta was cut open longitudinally.
sterile, polyurethane membrane patch (HeartMate) was sewn
Abbreviations and Acronyms
CFU  colony-forming units
LVAD left ventricular assist device
POD  postoperative daynto the aorta with 10-0 nylon running suture around the margin of m
148 The Journal of Thoracic and Cardiovascular Surgery ● Mahe patch under 25 magnification (Leitz Wild microscope M651;
ild Surgical Microscopes Co, Heerbrugg, Switzerland). After the
ascular clamp was removed, pulsatile flow was confirmed at the
istal part of the aorta. The operative field was irrigated with saline
olution, and the skin incision was closed. Buprenorphine was
iven subcutaneously for postoperative analgesia as necessary.
he animal was given 1 mL normal saline solution subcutaneously
nd put into a 36°C incubator for recovery. The entire procedure
ook approximately 45 minutes.
n Vivo Infection Model
aureus (Wb strain), an endocarditis isolate, was used in this
tudy.9,10 Susceptibility to infection was determined in a series of
ose escalation studies. One day after patch implantation, the mice
ere lightly anesthetized and received a tail vein injection con-
entration of 106, 107, or 108 colony-forming units (CFU) of
aureus (0.2 mL). A blood sample was obtained to confirm
acteremia 1 hour after inoculation. After infection, the mice were
ept in different cages to avoid cross infection. The mice were
illed 3 days after infection. Liver, kidneys, spleen, and the poly-
rethane patch were excised for bacterial assay. The tissue was
ashed in phosphate-buffered saline solution, weighed, and ho-
ogenized in phosphate-buffered saline solution; aliquots of the
omogenate were then plated onto mannitol salt agar plates (Bec-
on Dickinson Microbiology Systems, Sparks, Md). Each plate was
ncubated for 24 hours at 37°C, and the number of colonies was
etermined. Results were expressed as the CFU per gram of tissue.
Susceptibility to infection was also assessed across time. These
tudies were performed to test the hypothesis that time-dependent
hanges in polyurethane topology alter the susceptibility to infec-
ion. The mice were infected either 1 day or 14 days after patch
mplantation. After infection, the mice were processed in the same
anner as outlined for the dose escalation studies. Because dose
scalation and time dependencies were our variables of interest in
he context of this study, the time point at which the animals were
illed (3 days) was kept constant.
istologic Studies
fter they had been humanely killed, mice infected with S aureus
day after polyurethane patch implantation were perfused with
hosphate-buffered saline solution through a cardiac puncture in
he left ventricle at physiologic pressure with an infusion pump.
he aorta, including the patch, was excised from the body, em-
edded in OCT freezing compound (Sakura Finetek USA, Inc,
orrance, Calif), frozen, and stored at 80°C. Transverse sections
8 m) from the middle of the polyurethane patch were stained
ith hematoxylin and eosin or Gram stain.
n Vitro Assay Measuring Effect of Endothelial
ell Coating of Polyurethane Membranes on
Aureus Adhesion
n in vitro assay was developed to assess further the role of
ndothelialization in reducing bacterial adhesion to the polyure-
hane membrane. Endothelial cells (Cambrex Corporation, East
utherford, NJ) were grown to confluence in endothelial cell
rowth medium.9 Adhesion of S aureus to fibrinogen- versus
ndothelial cell–coated membranes was then compared with a
odification of a previously described adhesion assay.9,11 LVAD
y 2007
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Pembrane (diameter 0.5 cm) was immobilized on the bottom of a
6-well tissue culture dish (Becton, Dickinson and Company,
ranklin Lakes, NJ). Fibrinogen (0.5 mg/mL; Sigma, St Louis,
o) was added to the membrane-containing wells and incubated
vernight at 37°C. The next day wells were washed, seeded with
ndothelial cells, and incubated in endothelial cell growth media at
7°C in 5% carbon dioxide for an additional 2 days.
S aureus (Wb strain) was grown overnight in Todd Hewitt
roth (Becton Dickinson). The next morning, an aliquot from the
vernight sample was diluted and reincubated for 3 hours to bring
he suspension to logarithmic growth phase. The sample was then
entrifuged and resuspended in 2 mL M199 Earle Salts (Invitrogen
orporation, Carlsbad, Calif), and the suspension was adjusted to
n optical density at 600 nm of 0.01.
The membrane-containing microtiter wells were washed once
ith Medium 199 (Invitrogen). The staphylococcal suspension
as vortex mixed, and 100 L was added to the membranes coated
ith either endothelial cells or fibrinogen. The microtiter plate was
ncubated at 37°C for 1 hour. The bacterial suspensions were then
spirated and the wells washed with Medium 199 at 37°C for 5
inutes at 80 rpm. The bacteria and cells were lifted with trypsin–
thylenediaminetetraacetic acid (Invitrogen). The number of en-
othelial cells per well was determined with a hemocytometer.
liquots (100 L) of the trypsin-digested samples were plated
nto heart infusion Agar (Becton Dickinson) and incubated over-
ight at 37°C. The colonies grown in the plates were counted, and
he results were expressed as the number of bacteria per well. Each
ssay was performed with 12 wells per condition and was repeated
our times.
tatistical Analysis
ata were compared with an unpaired Student t test.
esults
urine Infection Model
he mouse surgical survival rate was 77.5%, and the pa-
ency of the aorta was 100%. There were no unexpected
eaths perioperatively before bacterial inoculation. All mice
nfected with a bacterial inoculum of 108 CFU (n  8) died
ithin 24 hours. These animals were severely ill, exhibiting
igns of inactivity, sweating, shivering. All animals infected
ith 106 or 107 CFU survived. The animals in these groups
lso showed signs of illness with inactivity and sweating but
id not appear as ill as the animals in the group infected
ith 108 CFU. Two of 7 mice in the 106 CFU group were
ot bacteremic at 1 hour, whereas all animals in the 107
FU group were bacteremic. Mice infected with 107 CFU
ad a higher grade of bacteremia than those infected with
06 CFU (106 CFU vs 107 CFU 0.6 0.6 vs 2.5 0.2, P
001).
Dose-dependence assay. Five of 7 polyurethane patches
btained from the mice infected with 106 CFU were sterile.
ll samples obtained from animals inoculated at 107 CFU
ere infected (106 CFU vs 107 CFU 1.1 1.9 vs 6.8 1.2,
  .001; Figure 1, A). The kidney and liver homogenates
ere all infected, regardless of the concentration of the (
The Journal of Thoracicnoculation. One spleen sample in the 106 CFU group was
terile. The organ bacterial density was higher in groups
nfected with the higher bacterial inoculum (106 CFU vs
07 CFU): kidneys, 4.6  2.1 versus 6.5  0.6 (P  .05;
igure 2, A ); liver, 3.4  0.7 versus 6.2  0.8 (P  .001;
igure 2, B ); and spleen, 2.9  1.2 versus 5.1  1.6 (P 
002; Figure 2, C ).
Time-dependence assay. For these experiments an inoc-
lum of 107 CFU was used to achieve 100% infection at 1
ay after polyurethane patch implantation. All animals were
acteremic 1 hour after infection. There was no difference
n bacterial density between the two groups (postoperative
ay [POD] 1 vs POD 14 2.5  0.2 vs 2.5  0.1, P  .46).
All tissue samples obtained from mice infected POD 1
igure 1. Bacterial density on surface of polyurethane membrane
days after inoculation. A, Animals were inoculated with differ-
nt concentrations of S aureus (106 and 107 colony-forming units
CFU]/mouse). B, Animals were infected days 1 and 14 after
olyurethane patch implantation. pod, Postoperative day.n  7) showed infection, whereas only 2 of 7 samples
and Cardiovascular Surgery ● Volume 133, Number 5 1149
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CSProm mice infected POD 14 (n  12) were infected. The
acterial densities in the patches from mice infected POD
were significantly higher than in those from mice
nfected POD 14 (POD 1 vs POD 14 6.8  1.2 vs 1.77 
.7, P  .002; Figure 1, B ).
There was no difference in the bacterial density of ho-
ogenates from the kidneys and livers between the two
roups. The number of bacteria in the spleen was lower in
he POD 14 group: kidneys, POD 1 vs POD 14, 6.5  0.6
ersus 5.6  0.5 (P  .23; Figure 2, D); liver, POD 1 versus
OD 14, 6.2  0.8 versus 5.2  2.0 (P  .14; Figure 2, E);
nd spleen, POD 1 versus POD 14, 5.1  1.6 versus 4.0 
.9 (P  .05; Figure 2, F).
istologic Studies
ne day after implantation, the polyurethane membrane
as covered with a homogeneous fibrin layer (Figure 3, A,
nd Figure 4, A). Some of the fibers remained uncoated and
n contact with the circulation. Polymorphonuclear leuko-
ytes and mononuclear cells were attached to the surface as
ell as embedded within the fibrin (Figure 3, A). Sections
btained from an animal infected with 107 CFU 1 day after
mplantation and killed at 3 days showed infiltration of the
ortic wall with polymorphonuclear leukocytes in addition
Figure 2. Bacterial density in organs 3 days after infe
different concentrations of S aureus (106 and 107 colon
days 1 and 14 after polyurethane patch implantation. po the findings in the noninfected animals (Figure 3, B). i
150 The Journal of Thoracic and Cardiovascular Surgery ● Maram-positive cocci were also observed in this tissue. Some
f the bacteria were attached directly to the fibers of the
olyurethane material, whereas some were seen embedded
n the fibrin layer (Figure 3, C). At day 14, the blood-
ontacting surface of the polyurethane membrane was to-
ally covered with CD31 cells; the morphology, location,
nd CD31 staining all suggest that these were endothelial
ells (Figure 4, B and C).
n Vitro Assay Measuring Effect of Endothelial
ell Coating of Polyurethane Membranes on
aureus Adhesion
he initial bacterial inoculum used in these in vitro assays
as 1.5  0.5  105 CFU/well. The average number of
ndothelial cells adherent to the polyurethane membrane
urface was 4.1 0.3 103 cells/well. There was a 10-fold
ecrease in the number of S aureus organisms adherent to
he surface of the polyurethane membrane coated with
D31 cells relative to membrane coated with fibrinogen,
uggesting that the CD31 cells created a barrier protecting
he patch from infection (Figure 5).
iscussion
n this study, we report the development of a reproduc-
with S aureus. A–C, Animals were inoculated with
ming units [CFU]/mouse). D–F, Animals were infected
ostoperative day.ction
y-for
od, Pble LVAD murine model of aortic patch infection. The
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Podel used textured polyurethane patch material from
he HeartMate LVAD implanted into the mouse descend-
ng aorta. There was 100% survival of the mice after
atch placement, as well as maintenance of pulsatile
Figure 4. A, Hematoxylin-eosin staining of representat
after implantation in aorta (Ao). Blood-contacting surfa
fibrin (f), and polymorphonuclear cells (PMN) are emb
cytes. B, Hematoxylin-eosin staining of representative
after implantation in aorta (Ao). Blood-contacting surfac
staining of representative section of implanted polyuret
reveals cells on luminal surface to be CD31 (arrows
has been covered with protective cell layer. These fin
Figure 3. A, Representative cross-section of aorta (Ao
with thin fibrin (f) layer (hematoxylin-eosin staining, or
of aorta (Ao) 4 days after polyurethane patch (P) imp
infected 1 day after implantation (hematoxylin-eosin s
clear cells. C, Cross-section obtained from same infe
original magnification 1000). Arrows indicate gram-peach group; original magnification 200). Insert shows 100
The Journal of Thoraciclood flow. This model allowed investigation of the
arameters that influence the susceptibility of this mate-
ial to subsequent infection. With S aureus, one of the
ost common pathogens in LVAD infections, we found
ection of implanted polyurethane membrane (P) 1 day
polyurethane membrane is covered with thin layer of
d with fibrin. Inserts show polymorphonuclear leuko-
ion of implanted polyurethane membrane (P) 14 days
polyurethane membrane is covered with cells. C, CD31
membrane (P) 14 days after implantation in aorta (Ao)
s suggests that after 14 days polyurethane membrane
were consistent for all animals examined (n  4 in
ay after polyurethane patch (P) implantation, covered
l magnification 50). B, Representative cross-section
tion, covered with thick fibrin (f) layer. Animal was
ng, original magnification 50) PMN, Polymorphonu-
animal was Gram stained (107 colony-forming units,
ve cocci. P, Polyurethane patch.ive s
ce of
edde
sect
e of
hane
). Thi
dings) 1 d
igina
lanta
taini
cted0 magnification of CD31 cells.
and Cardiovascular Surgery ● Volume 133, Number 5 1151
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1
CSPoth dose- and time-dependent susceptibilities to infection.
he patch material was significantly more susceptible to
nfection at 1 day after implantation than 14 days. The
istologic and in vitro studies provide a rationale for this
ltered susceptibility, the coating of the patch membrane
urface with a cellular monolayer over time.
Textured surface polyurethane material was originally
eveloped for clinical use to minimize the thromboembolic
vents that were frequently seen in patients who received
evices with a smooth blood-contacting surface. In compar-
son, devices with a textured blood-contacting surface (eg,
he HeartMate device) had a decreased rate of thromboem-
olic events, presumably as a result of the formation of a
eointima.7 Because the polyurethane membranes were less
usceptible to infection on day 14, when the patch was
oated with CD31 cells, we hypothesize from results in
his study that the neointima was also the basis for the
rotection against S aureus infection. The results from the in
itro assay provide further support for this hypothesis.
The reduced susceptibility to infection with time in our
nimal model is also consistent with the results of clinical
tudies of LVAD infections. These studies demonstrate that
ost bacterial infections occur within 2 months of device
mplantation.3,5,12 Although there are several potential rea-
ons for this, the absence of a cellular lining to the poly-
rethane membrane is one likely contributing factor. In a
elated in vitro study, Arrecubieta and colleagues23 demon-
trated that LVAD polyurethane membranes explanted from
atients after 6 months were significantly less susceptible to
aureus adhesion than LVADs explanted earlier than 6
onths.
The nature of the cellular lining of LVAD membranes
volves with time but has been found to include pluripotent
D34 hematopoietic cells, endothelial cells, macrophages,
igure 5. In vitro assay. Polyurethane membranes were fixed to
6-well tissue culture dishes and coated with fibrinogen. Half of
embranes were subsequently coated with human endothelial
ells and grown to confluence. Wb strain S aureus was added to
ells, and adhesion assay was performed. CFU, Colony-forming
nits.broblasts, monocytes, and smooth muscle cells.13-16 These
152 The Journal of Thoracic and Cardiovascular Surgery ● Maells eventually establish a protective barrier, reducing ex-
osure to the fibrinogen and fibrin deposited on the mem-
rane surface shortly after implantation. As a result, the
usceptibility to infection is reduced.
The cells lining the patch were CD31 and had the
orphologic appearance of endothelial cells. The identity of
hese cells as endothelial cells was not, however, confirmed
y another immunohistochemical marker. The contribution
f endothelial cells to the onset of endovascular infections is
ichotomous. On the one hand, endothelial cells provide a
ontinuous, protective barrier preventing access of bacteria
o underlying tissue. In this study, the aortic polyurethane
atch lined with CD31 cells appeared less susceptible to
nfection than patch material coated with matrix molecules
uch as fibrinogen. Previous studies, however, have also
emonstrated that S aureus is capable of direct adhesion to
ndothelial cells.11,17,18 This binding appears to primarily
ccur through the S aureus surface proteins fibronectin-
inding proteins A and B. These proteins are part of a
amily of structurally related proteins designated microbial
urface components recognizing adhesive matrix mole-
ules.19 These molecules are capable of adhering to matrix
nd cellular surfaces though a number of different receptor-
igand interactions.17,20
Our hypothesis is that fibrinogen, a serum component
nown to be deposited on prosthetic surfaces shortly after
mplantation, is more susceptible to S aureus adhesion than is
cellular layer. Reduction of exposure to fibrinogen by cellular
eposition reduces S aureus adhesion. Several proteins medi-
te adhesion to fibrinogen, including the fibronectin-binding
roteins and clumping factors A and B. The additional variable
f different parameters of flow has to date received limited
ttention; however, it does appear to affect the adhesion
nteraction.21
In conclusion, in our polyurethane aortic patch model of
nfection, the blood-contacting surface is covered with
D31 cells with time. In addition to preventing thrombo-
mbolism, this textured membrane therefore achieves an
lement of protection from bacterial infection by rapid cell
oating. This provides a potential strategy for future devices
n reducing the incidence of bacterial infections, which
onstitute a major complication of LVAD use.22,24
eferences
1. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM,
Francis GS, et al. ACC/AHA Guidelines for the Evaluation and Man-
agement of Chronic Heart Failure in the Adult: Executive Summary. A
Report of the American College of Cardiology/American Heart Asso-
ciation Task Force on Practice Guidelines (Committee to Revise the
1995 Guidelines for the Evaluation and Management of Heart Failure):
Developed in Collaboration With the International Society for Heart
and Lung Transplantation; Endorsed by the Heart Failure Society of
America. Circulation. 2001;104:2996-3007.
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW,
Dembitsky W, et al. Long-term mechanical left ventricular assistance
for end-stage heart failure. N Engl J Med. 2001;345:1435-43.
y 2007
11
1
1
1
1
1
1
1
1
2
2
2
2
2
Asai et al Cardiopulmonary Support and Physiology
CS
P3. Herrmann M, Weyand M, Greshake B, von Eiff C, Proctor RA, Scheld
HH, et al. Left ventricular assist device infection is associated with
increased mortality but is not a contraindication to transplantation.
Circulation. 1997;95:814-7.
4. Holman WL, Murrah CP, Ferguson ER, Bourge RC, McGiffin DC,
Kirklin JK. Infections during extended circulatory support: University
of Alabama at Birmingham experience 1989 to 1994. Ann Thorac
Surgery. 1996;61:366-73.
5. Holman WL, Park SJ, Long JW, Weinberg A, Gupta L, Tierney AR,
et al. Infection in permanent circulatory support: experience from the
REMATCH trial. J Heart Lung Transplant. 2004;23:1359-65.
6. Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A, et al.
Left ventricular assist device-related infection: treatment and outcome.
Clin Infect Dis. 2005;40:1108-15.
7. Slater JP, Rose EA, Levin HR, Frazier OH, Roberts JK, Weinberg
AD, et al. Low thromboembolic risk without anticoagulation using
advanced-design left ventricular assist devices. Ann Thorac Sur-
gery. 1996;62:1321-8.
8. Asai T, Baron HM, von Bayern MP, Sakaguchi T, Arrecubieta C,
Cespedes CA, et al. A mouse aortic patch model for mechanical
circulatory support. J Heart Lung Transplant. 2005;24:1129-32.
9. Tompkins DC, Hatcher VB, Patel D, Orr GA, Higgins LL, Lowy FD.
A human endothelial cell membrane protein that binds Staphylococcus
aureus in vitro. J Clin Invest. 1990;85:1248-54.
0. Yao L, Berman JW, Factor SM, Lowy FD. Correlation of histopatho-
logic and bacteriologic changes with cytokine expression in an exper-
imental murine model of bacteremic Staphylococcus aureus infection.
Infect Immun. 1997;65:3889-95.
1. Ogawa SK, Yurberg ER, Hatcher VB, Levitt MA, Lowy FD. Bacterial
adherence to human endothelial cells in vitro. Infect Immun. 1985;50:
218-24.
2. Sivaratnam K, Duggan JM. Left ventricular assist device infections:
three case reports and a review of the literature. ASAIO J. 2002;48:2-7.
3. Salih V, Graham TR, Berry CL, Coumbe A, Smith SC, Dasse K, et al.
The lining of textured surfaces in implantable left ventricular assist
devices. An immunocytochemical and electronmicroscopic study.
Am J Cardiovasc Pathol. 1993;4:317-25.
The Journal of Thoracic4. Spanier TB, Chen JM, Oz MC, Stern DM, Rose EA, Schmidt AM.
Time-dependent cellular population of textured-surface left ventricular
assist devices contributes to the development of a biphasic systemic
procoagulant response. J Thorac Cardiovasc Surg. 1999;118:404-13.
5. Menconi MJ, Owen T, Dasse KA, Stein G, Lian JB. Molecular
approaches to the characterization of cell and blood/biomaterial inter-
actions. J Card Surg. 1992;7:177-87.
6. Frazier OH, Baldwin RT, Eskin SG, Duncan JM. Immunochemical
identification of human endothelial cells on the lining of a ventricular
assist device. Tex Heart Inst J. 1993;20:78-82.
7. Peacock SJ, Foster TJ, Cameron BJ, Berendt AR. Bacterial fibronectin-
binding proteins and endothelial cell surface fibronectin mediate adher-
ence of Staphylococcus aureus to resting human endothelial cells. Micro-
biology. 1999;145 Pt 12:3477-86.
8. Hamill RJ, Vann JM, Proctor RA. Phagocytosis of Staphylococcus
aureus by cultured bovine aortic endothelial cells: model for postad-
herence events in endovascular infections. Infect Immun. 1986;54:
833-6.
9. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated
adherence of microorganisms to host tissues. Annu Rev Microbiol.
1994;48:585-617.
0. Sinha B, Francois PP, Nusse O, Foti M, Hartford OM, Vaudaux P, et
al. Fibronectin-binding protein acts as Staphylococcus aureus invasin
via fibronectin bridging to integrin alpha5beta1. Cell Microbiol. 1999;
1:101-17.
1. Reddy K, Ross JM. Shear stress prevents fibronectin binding protein-
mediated Staphylococcus aureus adhesion to resting endothelial cells.
Infect Immun. 2001;69:3472-5.
2. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos
R, et al. Mechanical circulatory support device database of the
International Society for Heart and Lung Transplantation: third
annual report—2005. J Heart Lung Transplant. 2005;24:1182-7.
3. Arrecubieta C, Asai T, Bayern M, Loughman A, Fitzgerald JR, Shel-
ton CE, et al. The role of Staphylococcus aureus adhesins in the
pathogenesis of ventricular assist device-related infections. J Infect
Dis. 2006;193:1109-19.
4. Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-
related infections. Lancet Infect Dis. 2006;6:426-37.
and Cardiovascular Surgery ● Volume 133, Number 5 1153
